These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 19748920

  • 1. IgM-rheumatoid factor and anti-cyclic citrullinated peptide decrease by 50% during intensive treatment in early rheumatoid arthritis.
    van Tuyl LH, Lems WF, Kerstens PJ, Voskuyl AE, Dijkmans BA, Boers M.
    Ann Rheum Dis; 2009 Oct; 68(10):1652-3. PubMed ID: 19748920
    [No Abstract] [Full Text] [Related]

  • 2. Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
    De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.
    Ann Rheum Dis; 2005 Feb; 64(2):299-302. PubMed ID: 15166003
    [Abstract] [Full Text] [Related]

  • 3. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH.
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [Abstract] [Full Text] [Related]

  • 4. The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia.
    van de Stadt LA, van der Horst AR, de Koning MH, Bos WH, Wolbink GJ, van de Stadt RJ, Pruijn GJ, Dijkmans BA, van Schaardenburg D, Hamann D.
    Ann Rheum Dis; 2011 Jan; 70(1):128-33. PubMed ID: 21062853
    [Abstract] [Full Text] [Related]

  • 5. IgM-rheumatoid factor, anti-cyclic citrullinated peptide, and anti-citrullinated human fibrinogen antibodies decrease during treatment with the tumor necrosis factor blocker infliximab in patients with rheumatoid arthritis.
    Vis M, Bos WH, Wolbink G, Voskuyl AE, Twisk JW, Van de Stadt R, Hamann D, Dijkmans BA, Lems WF.
    J Rheumatol; 2008 Mar; 35(3):425-8. PubMed ID: 18322974
    [Abstract] [Full Text] [Related]

  • 6. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors.
    Jørgensen KT, Wiik A, Pedersen M, Hedegaard CJ, Vestergaard BF, Gislefoss RE, Kvien TK, Wohlfahrt J, Bendtzen K, Frisch M.
    Ann Rheum Dis; 2008 Jun; 67(6):860-6. PubMed ID: 17644543
    [Abstract] [Full Text] [Related]

  • 7. Anti-cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis treated with anti-tumour necrosis factor agents.
    Russell AS, Maksymowych WP, de Silva M.
    Ann Rheum Dis; 2005 Dec; 64(12):1807. PubMed ID: 16284357
    [No Abstract] [Full Text] [Related]

  • 8. [Early prediction of joint destruction in rheumatoid arthritis].
    Eguchi K.
    Clin Calcium; 2007 Apr; 17(4):517-25. PubMed ID: 17404480
    [Abstract] [Full Text] [Related]

  • 9. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor.
    Bossuyt X, Coenen D, Fieuws S, Verschueren P, Westhovens R, Blanckaert N.
    Ann Rheum Dis; 2009 Feb; 68(2):287-9. PubMed ID: 19139208
    [No Abstract] [Full Text] [Related]

  • 10. Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis.
    Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G.
    J Rheumatol; 2008 Jul; 35(7):1256-64. PubMed ID: 18528969
    [Abstract] [Full Text] [Related]

  • 11. Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.
    Yamane T, Hashiramoto A, Tanaka Y, Tsumiyama K, Miura Y, Shiozawa K, Chihara K, Shiozawa S.
    J Rheumatol; 2008 Mar; 35(3):414-20. PubMed ID: 18203327
    [Abstract] [Full Text] [Related]

  • 12. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis.
    Kuriya B, Cheng CK, Chen HM, Bykerk VP.
    Ann Rheum Dis; 2009 Sep; 68(9):1482-5. PubMed ID: 19015211
    [Abstract] [Full Text] [Related]

  • 13. What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?
    Bobbio-Pallavicini F, Caporali R, Bugatti S, Montecucco C.
    J Rheumatol; 2008 Oct; 35(10):1903-5. PubMed ID: 18843754
    [No Abstract] [Full Text] [Related]

  • 14. Methotrexate effect on anti-cyclic citrullinated peptide antibody levels in rheumatoid arthritis.
    Spadaro A, Riccieri V.
    Ann Rheum Dis; 2005 Aug; 64(8):1241-2. PubMed ID: 16014691
    [No Abstract] [Full Text] [Related]

  • 15. [Immunologic laboratory testing in clinical practice for rheumatoid arthritis].
    Ota T.
    Rinsho Byori; 2006 Aug; 54(8):861-8. PubMed ID: 16989407
    [Abstract] [Full Text] [Related]

  • 16. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G.
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [Abstract] [Full Text] [Related]

  • 17. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Kitahara K, Takagi K, Kusunoki Y, Nishio S, Nozaki T, Inomata H, Takei M, Sawada S, Kawai S.
    Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
    [No Abstract] [Full Text] [Related]

  • 18. [Antibodies against cyclic citrullinated peptide indicate rheumatoid arthritis].
    Ljung L, Uddhammar A, Rantapää-Dahlqvist S.
    Lakartidningen; 2008 Jul; 106(32-33):1964-6. PubMed ID: 19764372
    [No Abstract] [Full Text] [Related]

  • 19. Duration of pre-rheumatoid arthritis anti-cyclic citrullinated peptide positivity is positively associated with age at seroconversion.
    Bos WH, Nielen MM, Dijkmans BA, van Schaardenburg D.
    Ann Rheum Dis; 2008 Nov; 67(11):1642. PubMed ID: 18854513
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic value of anti-cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome.
    van Noord C, Hooijkaas H, Dufour-van den Goorbergh BC, van Hagen PM, van Daele PL, van de Merwe JP.
    Ann Rheum Dis; 2005 Jan; 64(1):160-2. PubMed ID: 15608321
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.